ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparison of Two Antibiotic Regimen (Meropenem Versus Meropenem+Moxifloxacin)in the Treatment of Severe Sepsis and Septic Shock (MaxSep)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00534287
Recruitment Status : Completed
First Posted : September 24, 2007
Last Update Posted : June 29, 2012
Sponsor:
Collaborators:
AstraZeneca
Bayer
Information provided by (Responsible Party):
Kompetenznetz Sepsis

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2010
  Actual Study Completion Date : June 2010
Publications of Results:
Other Publications: